SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001587221-20-000014
Filing Date
2020-05-14
Accepted
2020-05-14 17:27:02
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zsan-03312020x10q.htm 10-Q 1087040
2 EXHIBIT 4.2 amendedserieseformofwarran.htm EX-4.2 123835
3 EXHIBIT 31.1 q1exhibit311.htm EX-31.1 10098
4 EXHIBIT 31.2 q1exhibit312.htm EX-31.2 10847
5 EXHIBIT 32.1 q1exhibit321.htm EX-32.1 13232
  Complete submission text file 0001587221-20-000014.txt   5688593

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT zsan-20200331.xml EX-101.INS 1139579
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20200331.xsd EX-101.SCH 50997
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20200331_cal.xml EX-101.CAL 87863
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20200331_def.xml EX-101.DEF 189286
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20200331_lab.xml EX-101.LAB 580601
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20200331_pre.xml EX-101.PRE 326099
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 20879172
SIC: 2834 Pharmaceutical Preparations